Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04503694
Title Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Intermediate-risk, Stage II-III Rectal Cancer (REGINA)
Acronym REGINA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jules Bordet Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries BEL

Facility Status City State Zip Country Details
Institut Jules Bordet RECRUITING Brussels 1000 Belgium Details
Erasme WITHDRAWN Brussels 1070 Belgium Details
Chirec Delta RECRUITING Bruxelles 1160 Belgium Details
Cliniques Universitaires Saint-Luc RECRUITING Bruxelles 1200 Belgium Details
Grand Hopital de Charleroi RECRUITING Charleroi 6000 Belgium Details
UZAntwerpen RECRUITING Edegem 2650 Belgium Details
UZ Gent RECRUITING Gent 9000 Belgium Details
AZ Groeninge RECRUITING Kortrijk 8500 Belgium Details
CHU Ambroise Paré RECRUITING Mons 7000 Belgium Details
CHR Namur RECRUITING Namur 5000 Belgium Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field